Arsenic Induces Functional Re-Expression of Estrogen Receptor α by Demethylation of DNA in Estrogen Receptor-Negative Human Breast Cancer
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Estrogen receptor α (ERα) is a marker predictive for response of breast cancers to endocrine therapy. About 30% of breast cancers, however, are hormone- independent because of lack of ERα expression. New strategies are needed for re-expression of ERα and sensitization of ER-negative breast cancer cells to selective ER modulators. The present report shows that arsenic trioxide induces reactivated ERα, providing a target for therapy with ER antagonists. Exposure of ER-negative breast cancer cells to arsenic trioxide leads to re-expression of ERα mRNA and functional ERα protein in in vitro and in vivo. Luciferase reporter gene assays and 3-(4,5-dimethylthiazol-2-yl)- 5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assays show that, upon exposure to arsenic trioxide, formerly unresponsive, ER-negative MDA-MB-231 breast cancer cells become responsive to ER antagonists, 4-hydroxytamoxifen and ICI 182,780. Furthermore, methylation- specific PCR and bisulfite-sequencing PCR assays show that arsenic trioxide induces partial demethylation of the ERα promoter. A methyl donor, S-adenosylmethionine (SAM), reduces the degree of arsenic trioxide-induced re-expression of ERα and demethylation. Moreover, Western blot and ChIP assays show that arsenic trioxide represses expression of DNMT1 and DNMT3a along with partial dissociation of DNMT1 from the ERα promoter. Thus, arsenic trioxide exhibits a previously undefined function which induces re-expression ERα in ER-negative breast cancer cells through demethylation of the ERα promoter. These findings could provide important information regarding the application of therapeutic agents targeting epigenetic changes in breast cancers and potential implication of arsenic trioxide as a new drug for the treatment of ER-negative human breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Arsenic is a Group 1 carcinogen that can increase the risk of breast cancer (54) and has been shown to induce expression of the estrogen receptor in human breast cancer (55).”
From The human tumor microbiome is composed of tumor type–specific intracellular bacteria (2020) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777 · cited 1×
“result of hypermethylation of CpG islands, cytosine–guanine-rich areas that are located in the 59 regulatory regions of the ER gene [2,7,8].”
BackgroundEstrogen receptor interaction with estrogen response elements
Klinge, C. M. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.14.2905 · Cited by 1,081
Chen, G., Shi, X., Tang, W., Xiong, S. M., Zhu, J., Cai, X., Han, Z., Ni, J.-H., Shi, G., Jia, P.-M., et al. (1997) · PubMed · Cited by 862
Mechanisms of arsenic biotransformation
Vahter, M. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00285-8 · Cited by 757 · cited 1×
“SAM as a methyl donor [34,35], the consumption of methyl groups in arsenic biotransformation presumably results in a”
BackgroundBreast cancer: origins and evolution
Polyak, K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33295 · Cited by 697 · cited 1×
“disease that is driven by epigenetic alterations, which do not affect the primary DNA sequence [5,6].”
Background(1990) · PubMed · Cited by 612
Ottaviano, Y. L., Issa, J. J., Parl, F. F., Smith, H. S., Baylin, S. B., & Davidson, N. E. (1994) · PubMed · Cited by 559
Yang, X., Phillips, D. L., Ferguson, A. T., Nelson, W. G., Herman, J. G., & Davidson, N. E. (2001) · PubMed · Cited by 500
DNA methylation controls the inducibility of the mouse metallothionein-I gene in lymphoid cells
Compere, S. J., & Palmiter, R. D. (1981) · Cell · doi:10.1016/0092-8674(81)90248-8 · Cited by 465 · cited 1×
“Arsenic methylation requires SAM as a cofactor and, as yet, largely uncharacterized methyltransferases (MeTases), including DNA MeTases (DNMTs), a group of enzymes responsible for DNA methylation. Expression of the DNMT gene has been definitively linked to methylation status”
BackgroundDNA methylation and breast carcinogenesis
Widschwendter, M., & Jones, P. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205606 · Cited by 457 · cited 1×
“disease that is driven by epigenetic alterations, which do not affect the primary DNA sequence [5,6].”
Background
Cited by
The human tumor microbiome is composed of tumor type–specific intracellular bacteria
Nejman, D., Livyatan, I., Fuks, G., Gavert, N., Zwang, Y., Geller, L. T., Rotter-Maskowitz, A., Weiser, R., Mallel, G., Gigi, E., et al. (2020) · Science · doi:10.1126/science.aay9189 · Cited by 2,464
DNMT1: A key drug target in triple-negative breast cancer
Wong, K. K. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.05.010 · Cited by 198
Koestler, D. C., Avissar-Whiting, M., Houseman, E. A., Karagas, M. R., & Marsit, C. J. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1205925 · Cited by 178
“…ESR1 is consistent with a report of decreased methylation and increased expression of ESR1 with in vitro arsenic exposure in a breast cancer model (Du et al. 2012), whereas the association with PPARGC1A is consistent with a report demonstrating up-regulation of this gene in arsenicinduced Bowen’s…”
ResultPremature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women
Honigberg, M. C., Zekavat, S. M., Niroula, A., Griffin, G. K., Bick, A. G., Pirruccello, J. P., Nakao, T., Whitsel, E. A., Farland, L. V., Laurie, C., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.051775 · Cited by 147
Genotoxic and epigenetic mechanisms in arsenic carcinogenicity
Bustaffa, E., Stoccoro, A., Bianchi, F., & Migliore, L. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1233-7 · Cited by 159
“At the same time, gene-specific hypomethylation of several genes, such as p16, RASSF1, E-cadherin, and GSTP1, was found (Cui et al. 2006a; Du et al. 2012).”
BackgroundBroberg, K., Ahmed, S., Engström, K., Hossain, M. B., Jurkovic Mlakar, S., Bottai, M., Grandér, M., Raqib, R., & Vahter, M. (2014) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174414000221 · Cited by 142
Lamb, R., Lehn, S., Rogerson, L., Clarke, R. B., & Landberg, G. (2013) · Cell Cycle · doi:10.4161/cc.25403 · Cited by 95
Zimța, A., Schițcu, V. H., Gurzau, E. S., Stăvaru, C., Manda, G., Szedlacsek, S. E., & Berindan‐Neagoe, I. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108700 · Cited by 88
Ji, H., Li, Y., Jiang, F., Wang, X., Zhang, J., Shen, J., & Yang, X. (2014) · Cancer Science · doi:10.1111/cas.12548 · Cited by 83
Self-citationEpigenetics of breast cancer: Modifying role of environmental and bioactive food compounds
Romagnolo, D. F., Daniels, K. D., Grunwald, J. T., Ramos, S. A., Propper, C. R., & Selmin, O. I. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201501063 · Cited by 96
“This was accompanied by reduced association of ESR1 with SUV39H1 [3].”
BackgroundInfluentialArsenic-protein interactions as a mechanism of arsenic toxicity
Vergara-Gerónimo, C. A., León‐Del‐Río, A., Rodríguez‐Dorantes, M., Ostrosky‐Wegman, P., & Salazar, A. M. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115738 · Cited by 85
Oncogenomic disruptions in arsenic-induced carcinogenesis
Sage, A. P., Minatel, B. C., Ng, K. W., Stewart, G. L., Dummer, T., Lam, W. L., & Martínez, V. D. (2017) · Oncotarget · doi:10.18632/oncotarget.15106 · Cited by 72
“Furthermore, widespread DNA hypomethylation in hepatocytes is implicated in the increased expression of pro-growth genes, particularly estrogen receptor-α [95, 96].”
BackgroundXu, Y., Tokar, E. J., & Waalkes, M. P. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1131-4 · Cited by 72
“The ABsolute SYBR Green ROX Mix (ABgene, Rockford, IL) was used for cDNA amplifications.”
BackgroundInfluentialWang, X., Jiang, F., Mu, J., Ye, X., Si, L., Ning, S., Zhong, L., & Li, Y. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.03.016 · Cited by 53
“Biotransformation of arsenic results in a deficiency of methyl donors, reducing DNA methylation, which activates a series of target genes (Miller et al., 2002; Du et al., 2012).”
InfluentialSelf-citationRecent advances on the stimulatory effects of metals in breast cancer
Lappano, R., Malaguarnera, R., Belfiore, A., & Maggiolini, M. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.10.017 · Cited by 56
“sensitization to endocrine therapy (Du et al., 2012), but also to induce a cancer-cell phenotype in human normal breast epithelial”
Vella, V., Malaguarnera, R., Lappano, R., Maggiolini, M., & Belfiore, A. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.10.020 · Cited by 60
Wang, Y., Jiang, F., Jiao, K., Ju, L., Liu, Q., Li, Y., Miao, L., & Li, Z. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111739 · Cited by 47
Self-citationRapid Reduction in Breast Cancer Mortality With Inorganic Arsenic in Drinking Water
Smith, A. H., Marshall, G., Yuan, Y., Steinmaus, C., Liaw, J., Smith, M. T., Wood, L., Heirich, M. S., Fritzemeier, R., Pegram, M. D., et al. (2014) · EBioMedicine · doi:10.1016/j.ebiom.2014.10.005 · Cited by 46
“For example, arsenic has been shown to cause induction of functional re-expression of the estrogen receptor in estrogen negative breast cancer cells, which could make them less aggressive (Du et al., 2012).”
BackgroundEarly life arsenic exposure and brain dopaminergic alterations in rats
Chandravanshi, L. P., Shukla, R. K., Sultana, S., Pant, A. B., & Khanna, V. K. (2014) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2014.08.009 · Cited by 46
Chandravanshi, L. P., Yadav, R. S., Shukla, R. K., Singh, A., Sultana, S., Pant, A. B., Parmar, D., & Khanna, V. K. (2014) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2014.01.007 · Cited by 45
“Risk of developing cancers of kidney, bladder, skin, lungs, breast and liver has been found to increase following arsenic exposure (Heck et al., 2009; Smith et al., 2009, 2012; Yuan et al., 2010; Yorifuji et al., 2011; Du et al., 2012).”
BackgroundInfluentialAnticancer mechanisms of phytochemical compounds: focusing on epigenetic targets
Omari, N. E., Bakha, M., Imtara, H., Guaouguaoua, F.-E., Balahbib, A., Zengin, G., & Bouyahya, A. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-15594-8 · Cited by 41
Arsenic alters global histone modifications in lymphocytes in vitro and in vivo
Pournara, A., Kippler, M. J., Holmlund, T., Ceder, R., Grafström, R., Vahter, M., Bröberg, K., & Wallberg, A. E. (2016) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9334-0 · Cited by 38
“Moreover, studies have shown that inorganic arsenic reduces the expression of DNA methyltransferase 1 (DNMT1), one of the enzymes responsible for DNA methylation (Du et al. 2012; Li et al. 2015).”
BackgroundPhookphan, P., Navasumrit, P., Waraprasit, S., Promvijit, J., Chaisatra, K., Ngaotepprutaram, T., & Ruchirawat, M. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.12.015 · Cited by 36
Prevention of arsenic-mediated reproductive toxicity in adult female rats by high protein diet
Mondal, S., Mukherjee, S., Chaudhuri, K., Kabir, S. N., & Mukhopadhyay, P. K. (2013) · Pharmaceutical Biology · doi:10.3109/13880209.2013.792846 · Cited by 36
“Arsenic possibly competitively binds to estrogen receptor (ER) and inhibits E2 binding to the ERa (Du et al., 2012).”
BackgroundEyvani, H., Moghaddaskho, F., Kabuli, M., Zekri, A., Momeny, M., Tavakkoly‐Bazzaz, J., Alimoghaddam, K., Ghavamzadeh, A., & Ghaffari, S. H. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.10.020 · Cited by 34
Wang, T., Garcia, J. G. N., & Zhang, W. (2012) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/187569212803901792 · Cited by 38
Mehta, K., Pandey, K. K., Kaur, B., Dhar, P., & Jhajhria, S. K. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05871-2 · Cited by 32
Naz, S., Shahzad, H., Ali, A., & Zia, M. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1375937 · Cited by 30
“Recent research reveals that As2O3 suppress cell growth and induces apoptosis to breast cancer [224] through inhibition of oestrogen receptor [225]; directive of p53 tumour suppressor protein and down instruction of Bcl-2 protein [226]; introduction of p21 as well as p27 tumour suppressor proteins [227]; induces demet…”
BackgroundDeb, M., Sengupta, D., Kar, S., Rath, S. K., Parbin, S., Shilpi, A., Roy, S., Das, G. C., & Patra, S. K. (2014) · Tumor Biology · doi:10.1007/s13277-014-2502-z · Cited by 28
Mass Spectrometry for Investigating the Effects of Toxic Metals on Nucleic Acid Modifications
Xiong, J., Yuan, B., & Feng, Y. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00042 · Cited by 27
Si, L., Jiang, F., Li, Y., Ye, X., Mu, J., Wang, X., Ning, S., Hu, C., & Li, Z. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22157 · Cited by 25
Self-citationLi, Y., Hu, Y., Dong, C., Lu, H., Zhang, C., Hu, Q., Li, S., Qin, H., Li, Z., & Wang, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146138 · Cited by 25
“Here, MBP decreased the expressions of DNMT3a and DNMT3b (two de novo methylation regulators [20]) in MLTC-1 cells (Fig 6C and 6D).”
BackgroundSelf-citationOestrogen receptor negativity in breast cancer: a cause or consequence?
Gajulapalli, V. N. R., Malisetty, V. L., Chitta, S. K., & Manavathi, B. (2016) · Bioscience Reports · doi:10.1042/bsr20160228 · Cited by 28
Bunker, S. K., Dutta, A., Pradhan, J., Dandapat, J., & Chainy, G. B. N. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.10.050 · Cited by 25
Maimaitiyiming, Y., Wang, Q. Q., Hsu, C.-H., & Naranmandura, H. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115212 · Cited by 18
The Role of Heavy Metals in the Biology of Female Cancers
Kozak, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115155 · Cited by 19
“The restoration of ER α expression by arsenic trioxide is sufficient to induce anti-estrogen responses in both ER-negative breast cancer cells and animal models [61].”
Jin, Z., Xue, Y., Yang, J., Zhou, M., Wu, P., & Yan, G. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s313962 · Cited by 17
RetractedAl‐Kabariti, A. Y., & Abbas, M. A. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-0321 · Cited by 16
Arsenic exposure increased expression of HOTAIR and LincRNA-p21 in vivo and vitro
Tan, J., Sun, M., Luo, Q., Sun, H., Wang, M., Jiang, C., Li, S., & He, Y. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-10487-8 · Cited by 15
Inorganic arsenic influences cell apoptosis by regulating the expression of MEG3 gene
Wang, M., Tan, J., Jiang, C., Li, S., Wu, X., Ni, G., & He, Y. (2020) · Environmental Geochemistry and Health · doi:10.1007/s10653-020-00740-x · Cited by 15
Wang, W., Tang, M., Zhang, L., Xu, X., Qi, X., Yang, Y., Jin, F., & Chen, B. (2013) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyt148 · Cited by 15
Novel Mechanistic Insights into the Anti-cancer Mode of Arsenic Trioxide
Wahiduzzaman, M., Ota, A., & Hosokawa, Y. (2019) · Current Cancer Drug Targets · doi:10.2174/1568009619666191021122006 · Cited by 15
Inorganic arsenic exposure increased expression of Fas and Bax gene in vivo and vitro
He, Y., Zhang, R., Song, X., Li, S., Wu, X., & Huang, D. (2018) · Gene · doi:10.1016/j.gene.2018.05.121 · Cited by 13
A high-throughput drug screen reveals means to differentiate triple-negative breast cancer
Vulin, M., Jehanno, C., Sethi, A., Correia, A. L., Obradović, M. M. S., Couto, J. P., Coissieux, M., Diepenbruck, M., Preca, B., Volkmann, K., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02429-0 · Cited by 13
Ye, X., Jiang, F., Li, Y., Mu, J., Si, L., Wang, X., Ning, S., & Li, Z. (2014) · Cancer Science · doi:10.1111/cas.12426 · Cited by 12
Self-citationRetractedLi, Y., Feng, C., Chen, Y., Huang, K., Li, C., Xiong, X., Li, P., Zhou, D., Peng, X., Weng, W., et al. (2021) · Technology in Cancer Research & Treatment · doi:10.1177/15330338211041454 · Cited by 11
He, Y., Zhang, R., Chen, J., Tan, J., Wang, M., & Wu, X. (2019) · Human & Experimental Toxicology · doi:10.1177/0960327119897101 · Cited by 10
“Arsenic exposure linked to changes in gene expression patterns in cells or populations.(17,19,20,38) Studies had shown that iAs could change the expression of apoptosis-related genes.”
BackgroundMethodZhang, F., Zhang, C., Li, S., Wang, K., Guo, B., Fu, Y. S., Liu, L., Zhang, Y., Jiang, H., & Wu, C. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8046 · Cited by 12
“Arsenic trioxide (As2O3) has been used to successfully treat acute promyelocytic leukemia (22,23) and other types of cancer cell lines (24-28).”
Arsenic-Induced Mutagenesis and Carcinogenesis
Maiti, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-418688-0.00009-5 · Cited by 11
Arsenic and 17-β-estradiol bind to each other and neutralize each other’s signaling effects
Kumar, S., Mukherjee, T. K., & Guptasarma, P. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.087 · Cited by 9
Ahmadi-Hadad, A., de Queiroz, P. C. C., Schettini, F., & Giuliano, M. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104516 · Cited by 11
Recio‐Vega, R., Dena‐Cazares, J. A., la Peña, J. L. R., Jacobo‐Ávila, A., Portales‐Castanedo, A., Gallegos‐Arreola, M. P., Ocampo‐Gómez, G., & Michel‐Ramirez, G. (2015) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21960 · Cited by 9
“Indeed, some studies have reported hypermethylation of different genes, such as TP53, MLH1, DBC1, FAM83A, ZSCAN12, and C1QTNF6, after chronic arsenic exposure [Mass et al., 2001; Chai et al., 2007; Jensen et al., 2009; Treas et al., 2013], whereas others have found hypome- thylation of others genes, such as p16, RASSF…”
BackgroundWang, Y., Wang, Z., Li, H., Xu, W., Dong, L., Guo, Y. H., Feng, S., Bi, K., & Zhu, C. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4184 · Cited by 8
“However, some studies have found that the metabolism of As 2 O 3 involves detoxification via methylation, which is similar to the methylation processes of oncogenes and tumor suppressor genes (20,21).”
Self-citationSkoczyńska, A., & Skoczyńska, M. (2022) · BioMed Research International · doi:10.1155/2022/8030931 · Cited by 7
“Arsenic induces functional reexpression of estrogen receptor alpha by demethylation of DNA in estrogen receptor-negative human breast cancer [22].”
Restoration of uterine redox-balance by methanolic extract of Camellia sinensis in arsenicated rats
Dey, A., Chattopadhyay, S., Jana, S., Giri, M. K., Khatun, S., Dash, M., Perveen, H., & Maity, M. (2018) · Acta Biologica Szegediensis · doi:10.14232/abs.2018.1.7-15 · Cited by 8
“2010), and arsenic has been shown to induce endometrial carcinogenicity or cellular toxicity that may lead to cell death (Du et al. 2012).”
BackgroundDong, C., Sun, Y., Xu, X., Li, H., Song, X., Wei, W., Jiao, C., Xu, H., Liu, Y., Mierzhakenmu, Z., et al. (2025) · Breast Cancer · doi:10.1007/s12282-025-01683-w · Cited by 5
Zhang, J., Li, S., Ma, M., & Li, S. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220818150959 · Cited by 5
Arsenic-induced mutagenesis and carcinogenesis: A possible mechanism
Maiti, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89847-8.00016-x · Cited by 3
Beauchamp, E. M., Serrano, R. M. T., & Platanias, L. C. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-8039-6_5 · Cited by 2
Jiang, Y., Wang, J., He, Z., Xiang, X., Yang, R., Wang, Q., & Cao, L. (2025) · PubMed Central · doi:10.11817/j.issn.1672-7347.2025.240591 · Cited by 4
“To address this, we employed propensity score matching (PSM) to balance confounding factors between the groups, thereby reducing bias and mitigating the occurrence of Simpson ’ s paradox [19-21] .”
Goettler, A., Haslberger, A. G., & Ambrosino, E. (2022) · Epidemiology Biostatistics and Public Health · doi:10.2427/11696 · Cited by 1
Transcriptional and epigenetic regulation of gene expression by arsenic in cancer and normal cells
Pournara, A. (2016) · Figshare
Saini, G., Kumar, S., & Kumar, R. (2023) · Environmental science and engineering · doi:10.1007/978-3-031-37561-3_16 · Cited by 1
Márquez-Mendoza, J. M., Baranda-Ávila, N., Lizano, M., & Langley, E. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167783 · Cited by 2
Zhang, Y., 陳曉豫, Shi, C., Fu, J., Chen, X., Shao, F., Xie, Z., & Yang, X. (2026) · Biological Trace Element Research · doi:10.1007/s12011-026-05260-w
Metadata
- Authors
- Du, J., Zhou, N., Liu, H., Jiang, F., Wang, Y., Hu, C., Qi, H., Zhong, C., Wang, X., & Li, Z.
- Affiliations
- Nanjing Medical University (CN)
- State Key Laboratory of Reproductive Medicine (CN)
- Corresponding author
- Li, Zhong
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-04-27
- Volume
- 7
- Issue
- 4
- Pages
- e35957
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3338760
- OpenAlex
- W2014235860
- Cited by
- 65
- References
- 43
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 5 · 2020: 6 · 2019: 5 · 2018: 3 · 2017: 4 · 2016: 10 · 2015: 2 · 2014: 10 · 2013: 6 · 2012: 1
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (30901186, 30972507, 863 Program)
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Qinglan Project of Jiangsu Province of China
- National High-tech Research and Development Program
- National Institute on Alcohol Abuse and Alcoholism (R21AA023001)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- arsenic trioxide, estrogen receptor alpha, estrogen receptor-negative breast cancer, promoter demethylation, DNA methylation, epigenetic reprogramming, DNMT1, DNMT3A, 4-hydroxytamoxifen, fulvestrant, S-adenosylmethionine, MDA-MB-231 cells, selective estrogen receptor modulators, endocrine therapy sensitivity
- MeSH terms
- DNA (Cytosine-5-)-Methyltransferase 1, Arsenic Trioxide, Animals, Arsenicals, Breast Neoplasms, DNA (Cytosine-5-)-Methyltransferases, DNA-Binding Proteins, Drug Screening Assays, Antitumor, Female, Humans, Mice, Nude, Neoplasm Proteins, Oxides, Promoter Regions, Genetic, Protein Binding, RNA, Messenger, Gene Expression Regulation, Neoplastic, Polymerase Chain Reaction, Sequence Analysis, DNA, CpG Islands, DNA Methylation, Cell Line, Tumor, Estrogen Receptor alpha, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.